Nephros Inc. NEPH

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

• GlobeNewswire Inc. 20 jul

  Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET

  Nephros, Inc. (Nasdaq: NEPH), a water technology and filtration solutions company, announced that its President and CEO Robert Banks will present at Maxim Group LLC's virtual 'Health, Wellness & Longevity' conference on July 22, 2026, at 10:00 a.m. ET. The conference brings together leaders from companies innovating in beverages, food, supplements, and longevity sectors to discuss consumer preferences and emerging trends.

  

• GlobeNewswire Inc. 18 jun

  Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”

  Nephros, Inc. announced a virtual investor event scheduled for July 16, 2026, titled 'Beyond Filtration: The Nephros Model in Action.' The event will showcase the company's differentiated approach to water safety beyond filtration products, featuring insights from field leaders, the Nephros Water Institute, and company leadership. The program will discuss growth opportunities, strategic priorities, and include a Q&A session.

  

• GlobeNewswire Inc. 16 jun

  Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water

  Nephros, Inc. announced that its ultrafiltration technology can effectively capture microplastics and nanoplastics from drinking water, positioning the company to address emerging water quality concerns. The announcement follows the U.S. EPA's April 2026 decision to include microplastics as a priority contaminant group under the Safe Drinking Water Act's draft Contaminant Candidate List (CCL 6). Nephros' filters feature pore sizes as small as 5 nanometers, enabling removal of particles smaller than conventional filtration technologies can address.